Chengguang Sui
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Pathology and Forensic Medicine
- Pharmaceutical Science top 10%
- Topics
- MicroRNA in disease regulation (6 papers)Epigenetics and DNA Methylation (6 papers)Cancer-related Molecular Pathways (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Chengguang Sui
40 papers receiving 699 citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 403
- Cancer Research 174
- Oncology 110
- Pathology and Forensic Medicine 56
- Pharmaceutical Science 56
Countries citing papers authored by Chengguang Sui
This map shows the geographic impact of Chengguang Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengguang Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengguang Sui more than expected).
Fields of papers citing papers by Chengguang Sui
This network shows the impact of papers produced by Chengguang Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengguang Sui. The network helps show where Chengguang Sui may publish in the future.
Co-authorship network of co-authors of Chengguang Sui
This figure shows the co-authorship network connecting the top 25 collaborators of Chengguang Sui. A scholar is included among the top collaborators of Chengguang Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengguang Sui. Chengguang Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 24 | |
| 3 | 70 | |
| 4 | 6 | |
| 5 | 21 | |
| 6 | 13 | |
| 7 | 4 | |
| 8 | 50 | |
| 9 | 7 | |
| 10 | 3 | |
| 11 | 16 | |
| 12 | 8 | |
| 13 | 30 | |
| 14 | 11 | |
| 15 | 17 | |
| 16 | 7 | |
| 17 | 7 | |
| 18 | 12 | |
| 19 | 12 | |
| 20 | 6 |
About Chengguang Sui
Chengguang Sui is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 40 papers that have together received 705 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Epigenetics and DNA Methylation (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (174 citations), Pharmaceutical Science (56 citations) and Molecular Biology (403 citations). Chengguang Sui has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Youhong Jiang, Fandong Meng, Ping Ma, Yuanqin Yin, Liye Fu, Yan Li, Xin Tian, Yunpeng Liu, Ning Li and Mi Wang. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.